Red flag 1: "Reversal" and "cure" guarantees
What it looks like: marketing that promises the program will "reverse" diabetes, "eliminate" medication, or deliver a guaranteed A1C drop. This language appears in search ads and social posts because it is persuasive and hard to verify.
Why it matters: Google's publisher content standards do not allow monetized content that promotes harmful health claims, or content related to a current major health crisis that contradicts authoritative scientific consensus. A blanket reversal or cure promise is the kind of claim this standard targets, because it asserts an outcome a reader cannot confirm from the program's own marketing.
What to do: ask for the actual evidence, the published study, the outcome data, and the methodology, then review it with your clinician. A program that cannot produce evidence beyond its own pages fails a basic trust test.
Red flag 2: Supplement bundles and prescription sales
What it looks like: a program whose core offer is a proprietary supplement pack, an herbal product containing active pharmaceutical ingredients, an ephedra-type formula, or medication sold without a prescription through an online pharmacy funnel.
Why it matters: Google restricts ad delivery on content that promotes unapproved drugs and supplements, including ephedra-containing products and herbal or dietary supplements with active pharmaceutical ingredients or dangerous components, and on content that facilitates online sale of prescription drugs. Restricted pages typically receive fewer ads, and Google Ads generally will not serve on them.
What this signals: a restriction is a policy classification, not proof a product is ineffective, but it is a strong screening cue. Credible programs do not need to sell unregulated supplements or route you around a licensed prescriber.
Red flag 3: Misleading marketing and invented authority
What it looks like: testimonials that read like medical endorsements, credentials that do not survive a registry search, unearned "as seen on" logos, and pages that misrepresent who runs the program or what you will actually receive.
Why it matters: Google's content standards prohibit misleading statements that distort or conceal information about the publisher or content, and prohibit promoting products or services through false or misleading claims. Its traffic rules add a related test: traffic to a page must be relevant to, and accurately describe, what users will find there.
What to do: verify the operator independently. Check qualifications through licensing boards or professional registries. Treat vague endorsements as marketing, not evidence. If the operator's identity cannot be checked, treat that as a red flag on its own.
Claim type vs. policy treatment: a quick comparison
The table below maps common offers to their policy treatment and what each signal means for you.
| Offer or claim you might see | Policy treatment | What it means for you |
|---|
| "Cure" or "reverse" diabetes guarantees | Conflicts with the rule against harmful health claims that contradict authoritative scientific consensus; restricted content | Demand the underlying evidence and confirm it with your clinician before taking any action |
| Program selling unapproved supplements or ephedra-type products as the core of the plan | Restricted under the unapproved drugs and supplements policy; pages typically receive fewer or no ads | A strong signal the program is not a credible medical offering |
| Medication offered for sale without a prescription or via an online pharmacy funnel | Restricted under the prescription drugs policy (online prescription sales) | Legitimate diabetes care requires a licensed prescriber; walk away |
| Vague endorsements, invented credentials, or claims that misrepresent who runs the program | Prohibited under misleading statements and deceptive-behavior policies | Verify the operator's real identity and qualifications independently |
The pattern is consistent: the claims platforms restrict are the same claims you should question hardest, though policy restrictions are a screening filter, not clinical evidence.
Five questions to ask before you enroll
Before you enter payment details or change how you manage your health, run the shortlist through these five questions.
- Who actually runs the program? Verify credentials through independent registries, not the program's own page.
- What evidence backs the claims? Look for published studies, outcome data, and methodology you can read, not summaries written by the program itself.
- What is included in the total price? List coaching, lessons, labs, and follow-up separately, and ask what costs extra.
- Does the plan require supplements or prescription sales? If the core offer is an unapproved supplement or medication without a prescription, that is a restricted-content signal.
- Has your clinician reviewed it? Have a licensed professional evaluate the program before you enroll or act on its advice.
What this guide does and does not tell you
This article is a vetting framework, not medical advice, and it names no specific program; the red flags are deliberately general so any offer can be tested against them.
The policy details deserve one caveat: Google's rules change over time, so check the current publisher policy pages for the latest treatment of health content. This guidance reflects US platform policy and reader context.
Most important is the boundary. Platform restrictions are a consumer-protection signal, not a clinical verdict, and no claim here is medical evidence. Whether a program fits your health situation is a question for a licensed clinician. Use the checklist to shortlist options, then bring your final candidate to your care team before enrolling.
Sources
研究の知恵